JNJ-1013 is a selective degrader of IRAK1, featuring a functional group that reduces IRAK1 levels and modulates key signaling molecules like p-IKBα and pSTAT3. It also promotes apoptosis and increases cleaved PARP expression, highlighting its impact on protein regulation and signaling pathways.
Usually ships within 24 hours.